Circumvention of COVID-19-related restrictions on tobacco sales by the e-cigarette industry in South Africa and comparative analyses of heated tobacco product vs combustible cigarette volume sales during 2018-2020.


Journal

Preventive medicine
ISSN: 1096-0260
Titre abrégé: Prev Med
Pays: United States
ID NLM: 0322116

Informations de publication

Date de publication:
07 2021
Historique:
received: 16 08 2020
revised: 28 12 2020
accepted: 16 03 2021
pubmed: 23 3 2021
medline: 16 6 2021
entrez: 22 3 2021
Statut: ppublish

Résumé

As a public health measure against COVID-19, South Africa restricted the sale of "tobacco, e-cigarettes and related products" for 5 months, ending on August 17, 2020. We examined marketing activities related to novel tobacco products (e-cigarettes and heated tobacco products) during this restriction. Using web scraping, we accessed data for 2661 e-cigarette liquids marketed online by South African vendors in June 2020. We also analyzed heated tobacco product volume sales (kits) using retail scanner data from Nielsen Company. The 2661 e-cigarette liquids assessed online comprised cannabidiol liquids, 28.8%[767/2661], nicotine salts, 10.4%[276/2661], e-cigarette juice concentrates, 14.1%[376/2661], nicotine-free e-liquid, 4.0%[107/2661], and nicotine-containing e-liquid, 42.6%[1135/2661]. Cannabidiol liquids had the highest percentage of fruit (78.4%[601/767]) and tobacco flavors (9.4%[72/767]). During the restriction, many online e-cigarette vendors actively promoted cannabidiol liquid in lieu of regular e-liquid. Nielsen retail scanner data showed that volume of heated tobacco product sales in February 2020, preceding the restriction (7.76 million kits), were higher than in February 2019 (4.52 million kits). The restriction saw decreased sales of heated tobacco products; mean weekly heated tobacco product sales in the 6 weeks following the restriction (772,585 kits/week) were dramatically lower versus the 6 weeks preceding the restriction (2.26 million kits/week). Lifting the restriction saw a 131% spike in sales between the latter half of August 2020 (825,638 kits) and mid-September 2020 sales (1.90 million kits), even though total sales in September 2020 were half of what was observed in the preceding year (3.81 million units in September 2020, vs 6.33 million units, September 2019). The marketing of cannabidiol and other novel products by e-cigarette manufacturers and the tobacco industry may encourage youth use; close monitoring is required.

Identifiants

pubmed: 33745955
pii: S0091-7435(21)00110-9
doi: 10.1016/j.ypmed.2021.106526
pmc: PMC8570646
pii:
doi:

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

106526

Informations de copyright

Copyright © 2021. Published by Elsevier Inc.

Références

Nicotine Tob Res. 2018 May 3;20(6):698-706
pubmed: 28575408
Tob Control. 2019 Jul;28(4):394-400
pubmed: 30068564
JAMA Netw Open. 2020 Dec 1;3(12):e2030189
pubmed: 33351085
IEEE Trans Vis Comput Graph. 2014 Dec;20(12):1983-92
pubmed: 26356912
Nicotine Tob Res. 2017 Feb;19(2):141-148
pubmed: 27613902
Tob Control. 2021 Mar;30(2):237-238
pubmed: 32269175
JAMA Netw Open. 2019 Oct 2;2(10):e1913853
pubmed: 31642924
Tob Induc Dis. 2020 May 06;18:39
pubmed: 32395100
Subst Use Misuse. 2020;55(7):1138-1145
pubmed: 32093530
Tob Control. 2018 Mar;27(2):123-124
pubmed: 29475955
Prev Med Rep. 2020 Sep 12;20:101208
pubmed: 32995147
J Epidemiol Community Health. 2006 Sep;60 Suppl 2:34-43
pubmed: 17708009
Forensic Sci Int. 2020 May;310:110261
pubmed: 32229319
MMWR Morb Mortal Wkly Rep. 2015 Oct 02;64(38):1066-70
pubmed: 26421418
Lancet Infect Dis. 2020 May;20(5):533-534
pubmed: 32087114
N Engl J Med. 2020 Jun 11;382(24):e95
pubmed: 32469479
J Law Biosci. 2020 Jul 07;7(1):lsaa052
pubmed: 32908671
Cochrane Database Syst Rev. 2016 Feb 04;2:CD005992
pubmed: 26842828
Tob Control. 2020 Sep;29(5):537-547
pubmed: 31537629

Auteurs

Israel T Agaku (IT)

School of Health System & Public Health, University of Pretoria, Pretoria, South Africa; Department of Oral Health Policy and Epidemiology, Harvard School of Dental Medicine, Boston, MA, United States. Electronic address: u16218435@tuks.co.za.

Catherine O Egbe (CO)

Alcohol, Tobacco and Other Drug Research Unit, South African Medical Research Council, Pretoria, South Africa; Department of Public Health, Sefako Makgatho Health Sciences University, Pretoria, South Africa.

Olalekan A Ayo-Yusuf (OA)

School of Health System & Public Health, University of Pretoria, Pretoria, South Africa; Africa Centre for Tobacco Industry Monitoring and Policy Research, Sefako Makgatho Health Sciences University, Pretoria, South Africa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH